Rheumatoid arthritis (RA) is a medical condition in which the body’s own immune system attacks its joint tissues, which leads to inflammation of joint lining. It is a type of autoimmune disease. Inflammation in joint lining causes stiffness, pain, swelling, warmth, and redness.
Statistics:
The global rheumatoid arthritis diagnostic tests market is estimated to account for US$ 3,480.9 Mn in terms of value by the end of 2027
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/3716
Global Rheumatoid Arthritis Diagnostic Tests Market: Drivers
Growing prevalence of RA is projected to propel growth of the global rheumatoid arthritis diagnostic tests market. For instance, according to the study, “Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017”, published in the journal Annals of the Rheumatic Diseases, in November 2019, the age-standardized point prevalence and annual incidence rates of RA were 246.6 and 14.9 in 2017, which increased by 7.4% and 8.2% from 1990, respectively.
Moreover, growing expenditure for the treatment and management of RA is again expected to support growth of the market. For instance, according to the study, “Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study”, published in the journal PLOS One in January 2019, the annual health expenditures were significantly larger for patients with RA than for controls.
Asia Pacific held leading position in the global rheumatoid arthritis diagnostic tests market in 2019, accounting for 41.1% share in terms of value, followed by Europe, respectively
Figure 1. Global Rheumatoid Arthritis Diagnostic Tests Market Share (%), by Region, 2019
Source: Coherent Market Insights Analysis (2020)
Global Rheumatoid Arthritis Diagnostic Tests Market: Restraints
Limited specificity and sensitivity of test kits available in the market is projected to restrict growth of the global rheumatoid arthritis diagnostic tests market.
Moreover, lack of effective drugs for the treatment of RA is again projected to restrict growth of the market.
Global Rheumatoid Arthritis Diagnostic Tests Market: Opportunities
Advent of cost effective and reliable test kits is projected to offer lucrative growth opportunities for players in the market. At present, there are no effective diagnosis measures available for rheumatoid arthritis. The unavailability of effective diagnostic tools has triggered the need for cost effective and more reliable test kits. As a result, the companies engaged in this market are now focusing on the development of cost-effective and reliable test methods.
Moreover, R&D of biomarker-based diagnostic methods for RA is again projected to aid in growth of the market. For instance, in February 2020, researchers from Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Germany, reported that serum markers can be used to detect inflammation in patients in joint diseases.
The hospitals segment of global rheumatoid arthritis diagnostic tests market was valued at US$ 614.1 Mn in 2019 and is forecast to reach a value of US$ 1,062.8 Mn by 2027 at a CAGR of 7.1% between 2019 and 2027
Market Trends/Key Takeaways
In the recent past, the techniques for diagnosing RA have made significant progress in terms of rapid outcomes. The serology test is now being performed on the rapid diagnosis test platform, which helps in conducting RA test within the stipulated time. A large number of pathology centers are increasingly relying on such rapid diagnostic tools, owing to increasing in-patient visit for RA testing.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3716
Application of biomarker test for diagnosing RA is at an early stage of development. Many companies are focusing on the development of biomarker test, owing to the limited efficacy of test kits available in the current market. Presently, there is no biochemical test available for the diagnosis of RA. However, Rheumatoid Factor (RF) and Anti–Cyclic Citrullinated Peptide (anti–CCP) antibodies test require more refinement to improve their clinical utility.
Global Rheumatoid Arthritis Diagnostic Tests Market: Competitive Landscape
Major players operating in the global rheumatoid arthritis diagnostic tests market include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
Global Rheumatoid Arthritis Diagnostic Tests Market: Key Developments
Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, WorldCare Clinical, LLC, an independent CRO offering imaging in clinical trials partnered with Navidea Biopharmaceuticals, Inc. to offer imaging service following FDA approval of Navidea’s RA diagnostic.
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3716
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Rheumatoid Arthritis Diagnostic Tests Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Rheumatoid Arthritis Diagnostic Tests Industry Impact
Chapter 2 Global Rheumatoid Arthritis Diagnostic Tests Competition by Types, Applications, and Top Regions and Countries
2.1 Global Rheumatoid Arthritis Diagnostic Tests (Volume and Value) by Type
2.3 Global Rheumatoid Arthritis Diagnostic Tests (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Rheumatoid Arthritis Diagnostic Tests Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 6 East Asia Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 7 Europe Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 8 South Asia Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 9 Southeast Asia Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 10 Middle East Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 11 Africa Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 12 Oceania Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 13 South America Rheumatoid Arthritis Diagnostic Tests Market Analysis
Chapter 14 Company Profiles and Key Figures in Rheumatoid Arthritis Diagnostic Tests Business
Chapter 15 Global Rheumatoid Arthritis Diagnostic Tests Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
View Press Release: https://www.coherentmarketinsights.com/press-release/rheumatoid-arthritis-diagnostic-tests-market-3013
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 9815, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837